In-depth coverage and real-time reporting for the Healthcare & Pharma sector. Professional analysis for industry leaders.
Analysis of the global pharmaceutical market concentration, focusing on the growth drivers in oncology and the rapid ascent of obesity as a top therapy area, with implications for investment and policy.
An analysis of the leading healthcare consulting services companies shaping innovation and market growth through digital transformation, AI, and strategic advisory up to 2030.
Analysis of the projected USD 3.20 trillion pharmaceutical market size by 2035, driven by chronic disease prevalence, biologics, and AI in drug development.
Analyzing the shift in the pharmaceutical sector towards AI-driven R&D, personalized patient experiences, and sustainable cost models as the industry navigates new challenges.
An analysis of the evolving business models within the biopharmaceutical sector, highlighting key strategic shifts and opportunities for investment and corporate strategy through 2026.
As GLP-1 therapies move from specialist niche to mass-market category, prescribing decisions are increasingly shaped by digital research behavior. Industry analysis points to behavioral segmentation, lifecycle timing and down-funnel metrics as the new basis of commercial competition in obesity care.